Revised SPC: Opdivo (nivolumab) 10 mg/mL concentrate for solution for infusion
SPC updated to warn that immune-related adverse reactions affecting more than one body system can occur simultaneously.
Source:
electronic Medicines compendium
SPC updated to warn that immune-related adverse reactions affecting more than one body system can occur simultaneously.
electronic Medicines compendium